Protocol · Eating pattern
Time-restricted eating
Weight loss as a calorie-adherence tool
Evidence type: Randomized trials
The graded dose: Daily eating window of 8 hours (studied range 6 to 10 hours), no prescribed calorie target in the popular form. Frequency in the evidence: Daily. The grade attaches to this dose; below it, the grade does not apply.
The caveat: The metabolic-superiority claim grades C- and the longevity claim D+. The supported use is narrower: a window that helps some people eat less.
Time cost
0 minutes / week
No session time. The cost is a schedule constraint, not minutes.
Dollar cost
Free
Free
Every claim, graded
Each outcome this protocol is claimed to deliver carries its own grade and its own kind of evidence. A strong secondary outcome never launders a weak popular claim: the popular claim prints at its own grade, next to the headline.
| Claim | Grade | Evidence | What the data show |
|---|---|---|---|
| Weight loss as a calorie-adherence tool | C | rctRandomized trials | People lose weight on TRE roughly in proportion to the calories the window removes. On superiority over calorie restriction, the best trial is a clean null: Liu 2022 (NEJM, n=139, 12 months) found TRE plus calorie restriction lost 8.0 kg vs 6.3 kg for calorie restriction alone, a non-significant minus 1.8 kg, with no significant differences in waist, body fat, blood pressure, lipids, or insulin resistance. TREAT 2020 (JAMA Internal Medicine) found no significant weight advantage for 16:8, with a secondary signal that a notable share of the small loss was lean mass.Liu D et al., New England Journal of Medicine, 2022; Lowe DA et al. (TREAT), JAMA Internal Medicine, 2020 |
| Metabolic improvement independent of weight loss | C- | rctRandomized trials | One small rigorous trial: Sutton 2018 (Cell Metabolism), supervised crossover, n=8 men with prediabetes, weight held constant; a 6-hour early window improved insulin sensitivity and beta-cell responsiveness and lowered blood pressure about 11/10 mmHg. Striking, tiny, fully supervised, unreplicated at scale. Hutchison 2019 (n=15) found glucose tolerance improved with both early and delayed 9-hour windows over 7 days.Sutton EF et al., Cell Metabolism, 2018; Hutchison AT et al., Obesity, 2019 |
| Longevity and autophagy benefits (the popular claim)Popular claim, graded on its own evidence | D+ | mechanisticMechanism only | POPULAR CLAIM DISCLOSURE: animal and mechanism data only. No human outcome data.Longevity Lab Report evidence review, 2026-10-18 |
Dose and response
Window placement is the dose variable with any signal: the only positive metabolic trial used an EARLY window (last food before 3 pm); the null weight trials used later windows. Early placement has the better (still thin) evidence and the worse real-world adherence.
Equipment that can deliver this dose: None required.
Harms and cautions
Harms live in this ledger, not inside the grade: the grade is evidence for the claimed outcomes in the studied population.
Medication interactions
Flagged medication classes: Diabetes medication (insulin, sulfonylureas, SGLT2 inhibitors). If you take any of these, the standing rule is a clinician conversation first, never a bare instruction from a website.
Hypoglycemia risk with insulin and sulfonylureas when meals are skippedserious
Medication users require clinician involvement before any fasting pattern
Source: Longevity Lab Report evidence review, 2026-10-18
Euglycemic ketoacidosis risk context with SGLT2 inhibitors during fastingserious
Medication users require clinician involvement
Source: Longevity Lab Report evidence review, 2026-10-18
Goal conflicts and timing
No goal conflicts in this record.
Daily including weekends in the trials. Time of day is the intervention: early windows carry the only positive metabolic signal.
Population exclusions and other cautions
Eating-disorder historyserious
Population exclusion
Source: Longevity Lab Report evidence review, 2026-10-18
Pregnancycaution
Population exclusion
Source: Longevity Lab Report evidence review, 2026-10-18
Lean mass loss during weight loss without resistance training and protein attentioncaution
Pair with the resistance minimum and protein target records
Source: TREAT secondary signal, 2020
Can you measure it yourself?
Weight loss as a calorie-adherence tool
- Metric
- Weight trend (7-day average of daily weights)
- Method
- Home scale, same conditions
- Baseline
- 2 weeks of usual eating
- Minimum run
- 8 weeks; retest: Weekly trend review
Noise note: Day-to-day noise is 0.5 to 1 kg; act only on a consistent 1 kg trend. HbA1c, where relevant, needs a minimum of 12 weeks by red-cell lifespan.
Outcomes without a measurement block carry none because no effect is established for them: a self-experiment cannot test a claim the evidence has not made.
Related graded records
- Resistance training, minimum effective dose →
The record's harm ledger pairs the eating window with resistance training against lean-mass loss during weight loss.
- Protein intake target (1.6 g/kg/day) →
The same ledger entry pairs the window with protein attention; the target record carries the graded dose.
Goals served
None at the serving floor
Derived from outcomes grading B- or better, never hand-assigned.
Experience gate
beginner and up (gated for safety)
Applicability
targeted
Applies to a specific goal or population, not broadly.
Grades are research summaries, not medical advice. Decisions about your own stack belong with your clinician.
Longevity Lab Report
Protocol news, graded when it happens.
The grades on this page stay free. The email is the week's longevity and biotech news in plain English: biotech news, expert moves, what is working, and new supplements and peptides, each story linked to the grades on this site.
Frequently asked questions
What grade does Time-restricted eating get?
At the studied dose (an 8-hour daily eating window), Time-restricted eating grades C for weight loss as a calorie-adherence tool, on randomized trials. The grade attaches to that dose; below it, the grade does not apply.
How much time does Time-restricted eating take each week?
At the graded dose, 0 minutes per week, counted as session time plus standard overhead, travel excluded. Dollar cost: Free.
Does Time-restricted eating deliver its most popular claim?
The popular claim (Longevity and autophagy benefits) grades D+. POPULAR CLAIM DISCLOSURE: animal and mechanism data only. No human outcome data.
Who should not use Time-restricted eating?
Hypoglycemia risk with insulin and sulfonylureas when meals are skipped. Medication users require clinician involvement before any fasting pattern. The full harm ledger is on this page, and the medical line applies: decisions about your own stack belong with your clinician.
Sources
- Liu D et al. Calorie restriction with or without time-restricted eating in weight loss. NEJM, 2022. (2022)
- Lowe DA et al. Effects of time-restricted eating on weight loss (TREAT). JAMA Internal Medicine, 2020. (2020)
- Sutton EF et al. Early time-restricted feeding improves insulin sensitivity. Cell Metabolism, 2018. (2018)
Last reviewed October 18, 2026
- 2026-10-18|Initial grading from the 2026-10-18 protocol inventory evidence review.
- 2026-10-18|Update: goal assignments are now recorded for each outcome individually, not only for the record as a whole. No grades, doses, or claims changed.